Skip to content

Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram

Detection of Left Atrial Appendage Thrombus in Patients Referred For Cardioversion: Comparative Analysis of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00797576
Enrollment
25
Registered
2008-11-25
Start date
2008-06-30
Completion date
2010-07-31
Last updated
2010-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Left Atrial Appendage Thrombi

Keywords

left atrial appendage thrombi, transesophageal echocardiogram, cardiac magnetic resonance imaging, atrial fibrillation, cardioversion

Brief summary

The purpose of this study is to compare Cardiac Magnetic Resonance (CMR) Imaging with transesophageal echocardiography (TEE) in detecting the presence of LAA thrombi in men and women with atrial fibrillation presenting for cardioversion.

Detailed description

The identification of left atrial appendage (LAA) thrombus prior to cardioversion for patients with atrial fibrillation is crucial. LAA thrombus can be a frequent cause of cerebral stroke or peripheral embolism post cardioversion, and anticoagulation therapy is required in these instances to prevent cerebral events and avoid embolization. To date, TEE has been considered the clinical reference in detection of LAA thrombi with high diagnostic accuracy. However, diagnosis and size estimation of LAA thrombi remains challenging due to the complex anatomy of the LAA, and transesophageal echocardiography (TEE) is considered a semi-invasive procedure. To date, there have been few comparative studies involving TEE and cardiac magnetic resonance (CMR) imaging, and the results have been conflicting. With newer CMR Imaging techniques now available, we hypothesize that comparable results will be achieved in detecting LAA thrombus in subjects using a less invasive procedure.

Interventions

None listed

Sponsors

Gundersen Lutheran Health System
CollaboratorOTHER
Gundersen Lutheran Medical Foundation
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* atrial fibrillation

Exclusion criteria

* ICDs * pacemakers * intracranial clips * intracranial stimulator devices * insulin pumps * intra ocular metal foreign bodies * cochlear implants * LAA amputation as part of CABG and/or valve surgery * GFR \< 60 mL/min

Design outcomes

Primary

MeasureTime frame
Accuracy values for CMR Imaging for detection of LAA thrombus. (sensitivity, specificity, negative predictive value, and positive predictive value)24 hours

Countries

United States

Contacts

Primary ContactRaju G Ailiani, MD
rgailian@gundluth.org608-775-2595

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026